These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21178397)

  • 1. Second National Immunization Congress 2010: addressing vaccine financing for the future in the US.
    Shen AK; Sobzcyk E; Buchanan A; Wu L; Duggan-Goldstein S
    Hum Vaccin; 2011 Jan; 7(1):12-8. PubMed ID: 21178397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financing the delivery of vaccines to children and adolescents: challenges to the current system.
    Lindley MC; Shen AK; Orenstein WA; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S548-57. PubMed ID: 19948587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaps in vaccine financing for underinsured children in the United States.
    Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
    JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calling the shots: immunization finance policies and practices. Executive summary of the report of the Institute of Medicine.
    Guyer B; Smith DR; Chalk R
    Am J Prev Med; 2000 Oct; 19(3 Suppl):4-12. PubMed ID: 11024319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
    JAMA; 1999 Jul; 282(4):363-70. PubMed ID: 10432034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking financial flows for immunization in Honduras.
    Valdés W; Janusz CB; Molina Aguilera IB; Mendoza L; Díaz IY; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A85-92. PubMed ID: 25919182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult immunization. Summary of the National Vaccine Advisory Committee Report.
    Fedson DS
    JAMA; 1994 Oct; 272(14):1133-7. PubMed ID: 7933327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first national adult immunization summit 2012: implementing change through action.
    Shen AK; Bridges CB; Tan L
    Vaccine; 2013 Jan; 31(2):279-84. PubMed ID: 23174197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustaining GAVI-supported vaccine introductions in resource-poor countries.
    Zuber PL; El-Ziq I; Kaddar M; Ottosen AE; Rosenbaum K; Shirey M; Kamara L; Duclos P
    Vaccine; 2011 Apr; 29(17):3149-54. PubMed ID: 21354249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening global vaccine access for adolescents and adults.
    Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A
    Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.
    Jiang M; Jiang W; Yan X; Ma H; Zhou S; Ying X
    Int J Equity Health; 2024 Sep; 23(1):193. PubMed ID: 39334358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine.
    Kharbanda EO; Lee GM; Koenigs L;
    J Adolesc Health; 2011 Mar; 48(3):320-1. PubMed ID: 21338909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The U.S. vaccine and immunization enterprise: Working to sustain and foster vaccine innovation.
    Shen AK
    Hum Vaccin; 2009 Oct; 5(10):649-53. PubMed ID: 19713758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
    Andrus JK; Walker DG
    Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
    [No Abstract]   [Full Text] [Related]  

  • 19. Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes.
    Sosler S; Kallenberg J; Johnson HL
    Vaccine; 2015 May; 33 Suppl 1():A4-5. PubMed ID: 25919172
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary care physician perspectives on reimbursement for childhood immunizations.
    Freed GL; Cowan AE; Clark SJ
    Pediatrics; 2009 Dec; 124 Suppl 5():S466-71. PubMed ID: 19948578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.